secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immuneering Corp (IMRX)
CIK:        0001790340
Form:       8-K
Filed at:   2025-06-16T23:59:59+00:00
Accession:  0001790340-25-000063
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Immuneering annual meeting: all three director nominees elected, auditor ratified
--------------------------------------------------------------------------------

- 69.1% of outstanding Class A common stock represented at June 13, 2025 meeting.
- Ann E. Berman, Diana F. Hausman, M.D., and Thomas J. Schall, Ph.D. elected as Class I directors.
- RSM US LLP ratified as independent auditor for fiscal year ending December 31, 2025.
- Broker non-votes of 10,009,639 on director elections; no broker non-votes on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1790340/000179034025000063/0001790340-25-000063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1790340/000179034025000063/imrx-20250613.htm
  HTML page:      https://secwatch.observer/filing/0001790340-25-000063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer